Early and late adverse clinical outcomes of severe carbon monoxide intoxication: A cross-sectional retrospective study
PLOS ONE · 30.08.2024 · 19 (8) · e0301399
DOI: 10.1371/journal.pone.0301399 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS ONE, online erschienen am 30.08.2024. Verfasst von Abdussamed Vural und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Nigde Omer Halisdemir University School of Medicine, Nigde, Turkey. Hauptthemen laut MEDLINE: Carbon Monoxide Poisoning, Hyperbaric Oxygenation, Hospital Mortality. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Carbon monoxide (CO) results from incomplete combustion of carbon-based materials, causing symptoms such as headaches, dizziness, nausea, chest pain, confusion, and, in severe cases, unconsciousness. Normobaric oxygen therapy (NBOT) is the standard therapy, whereas hyperbaric oxygen therapy (HBOT) is recommended in severe cases of organ damage. This study examined the early and late adverse outcomes in patients with severe CO poisoning. Materials and methods This study analyzed severe cases of CO poisoning among patients admitted to the emergency department between January 2020 and May 2022. The demographic, clinical, and laboratory data of symptomatic individuals and those requiring HBOT were examined. The study recorded early outcomes, such as intubation and in-hospital mortality, and late outcomes, such as delayed neurological sequelae and 1-year mortality. Chi-square tests, Spearman’s rho correlation tests, and logistic regression analyses were performed to identify factors affecting these outcomes.
Results
Patients who received HBOT showed a significant difference in delayed neurological sequelae (DNS) compared to those who received NBOT (p = 0.037). Significant differences were observed in the need for intubation, in-hospital mortality, and 1-year mortality between patients based on COHb levels, but no significant differences were found in DNS. The 1-year mortality probability was significantly influenced by COHb level (odds ratio = 1.159, 95% CI [1.056–1.273]). Patients receiving NBOT had a higher odds ratio for DNS risk than those receiving HBOT (odds ratio = 8.464, 95% [1.755–40.817], p = 0.008).
Conclusion
The study showed no differences in intubation, in-hospital mortality, and 1-year mortality rates between the HBOT and NBOT groups. However, significant differences in DNS suggest that treatment modalities have different effects on neurological outcomes. High COHb levels are associated with an increased risk of intubation, and mortality underscores the significance of monitoring COHb levels in clinical evaluations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Emergency Medicine, Nigde Omer Halisdemir University School of Medicine, Nigde, Turkey.
ORCID-Profile: Abdussamed Vural, Turgut Dolanbay
Zitieren
APA
Vural, A., & Dolanbay, T. (2024). Early and late adverse clinical outcomes of severe carbon monoxide intoxication: A cross-sectional retrospective study. PLOS ONE, 19(8), e0301399. https://doi.org/10.1371/journal.pone.0301399
Vancouver
Vural A, Dolanbay T. Early and late adverse clinical outcomes of severe carbon monoxide intoxication: A cross-sectional retrospective study. PLOS ONE. 2024;19(8):e0301399. doi:10.1371/journal.pone.0301399
BibTeX
@article{Vural2024,
author = {Vural, Abdussamed and Dolanbay, Turgut},
title = {Early and late adverse clinical outcomes of severe carbon monoxide intoxication: A cross-sectional retrospective study},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {8},
pages = {e0301399},
doi = {10.1371/journal.pone.0301399}
}
EUVIMED